Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 170

Similar articles for PubMed (Select 3670523)

1.
2.

Streptomyces coelicolor SCO4226 is a nickel binding protein.

Lu M, Jiang YL, Wang S, Jin H, Zhang RG, Virolle MJ, Chen Y, Zhou CZ.

PLoS One. 2014 Oct 6;9(10):e109660. doi: 10.1371/journal.pone.0109660. eCollection 2014.

3.

High-affinity Ni2+ binding selectively promotes binding of Helicobacter pylori NikR to its target urease promoter.

Zambelli B, Danielli A, Romagnoli S, Neyroz P, Ciurli S, Scarlato V.

J Mol Biol. 2008 Nov 28;383(5):1129-43. doi: 10.1016/j.jmb.2008.08.066. Epub 2008 Sep 4.

PMID:
18790698
4.
5.

The role of arginine vasopressin and its receptors in the normal and failing rat heart.

Chandrashekhar Y, Prahash AJ, Sen S, Gupta S, Roy S, Anand IS.

J Mol Cell Cardiol. 2003 May;35(5):495-504.

PMID:
12738231
6.

Role of aquaporin-2 gene expression in hyponatremic rats with chronic vasopressin-induced antidiuresis.

Saito T, Higashiyama M, Nagasaka S, Sasaki S, Saito T, Ishikawa SE.

Kidney Int. 2001 Oct;60(4):1266-76.

7.

Characterization of rodent liver and kidney AVP receptors: pharmacologic evidence for species differences.

Tahara A, Tsukada J, Ishii N, Tomura Y, Wada K, Kusayama T, Yatsu T, Uchida W, Tanaka A.

Regul Pept. 1999 Oct 22;84(1-3):13-9.

PMID:
10535403
8.

In vivo and in vitro evidence of blood-brain barrier transport of a novel cationic arginine-vasopressin fragment 4-9 analog.

Tanabe S, Shimohigashi Y, Nakayama Y, Makino T, Fujita T, Nose T, Tsujimoto G, Yokokura T, Naito M, Tsuruo T, Terasaki T.

J Pharmacol Exp Ther. 1999 Aug;290(2):561-8.

10.

Extracellular heavy-metal ions stimulate Ca2+ mobilization in hepatocytes.

McNulty TJ, Taylor CW.

Biochem J. 1999 May 1;339 ( Pt 3):555-61.

11.

Characterization of vasopressin receptor in rat lung.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Neuropeptides. 1998 Jun;32(3):281-6.

PMID:
10189064
12.

Effect of YM087, a potent nonpeptide vasopressin antagonist, on vasopressin-induced protein synthesis in neonatal rat cardiomyocyte.

Tahara A, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Cardiovasc Res. 1998 Apr;38(1):198-205.

13.

Regulation of agonist-receptor binding by G proteins and divalent cations in spermatozoa solubilized A1 adenosine receptors.

Minelli A, Allegrucci C, Rosati R, Mezzasoma I.

Mol Genet Metab. 1998 Mar;63(3):183-90.

PMID:
9608540
14.

Pharmacological characterization of YM087, a potent, nonpeptide human vasopressin V1A and V2 receptor antagonist.

Tahara A, Saito M, Sugimoto T, Tomura Y, Wada K, Kusayama T, Tsukada J, Ishii N, Yatsu T, Uchida W, Tanaka A.

Naunyn Schmiedebergs Arch Pharmacol. 1998 Jan;357(1):63-9.

PMID:
9459574
15.

Adenylyl cyclase isoforms and vasopressin enhancement of agonist-stimulated cAMP in vascular smooth muscle cells.

Zhang J, Sato M, Duzic E, Kubalak SW, Lanier SM, Webb JG.

Am J Physiol. 1997 Aug;273(2 Pt 2):H971-80.

PMID:
9277517
17.
18.

Solubilization of high-affinity, guanine nucleotide-sensitive mu-opioid receptors from rat brain membranes.

Weems HB, Chalecka-Franaszek E, Côté TE.

J Neurochem. 1996 Mar;66(3):1042-50.

PMID:
8769865
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk